Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Authors:
- Karen M. SmithKSKaren M. Smith
- Hoon RyuHRHoon Ryu
- Kerry CormierKCKerry Cormier
- Sean W. HagertySHSean W. Hagerty
- Steven J. Del SignoreSSSteven J. Del Signore
- Robert M. FriedlanderRFRobert M. Friedlander
- Robert J. FerranteRFRobert J. Ferrante
- 1 March 2006
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1762 (3) , 373-380
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic miceJournal of Comparative Neurology, 2005
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Experimental therapeutics in transgenic mouse models of Huntington's diseaseNature Reviews Neuroscience, 2004
- Depletion of wild‐type huntingtin in mouse models of neurologic diseasesJournal of Neurochemistry, 2003
- Transcriptional abnormalities in Huntington diseaseTrends in Genetics, 2003
- Therapeutic Effects of Coenzyme Q10and Remacemide in Transgenic Mouse Models of Huntington's DiseaseJournal of Neuroscience, 2002
- Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in miceNature Medicine, 2000
- Transcriptional dysregulation in Huntington’s diseaseTrends in Neurosciences, 2000
- Neuropathological Classification of Huntingtonʼs DiseaseJournal of Neuropathology & Experimental Neurology, 1985
- Selective Sparing of a Class of Striatal Neurons in Huntington's DiseaseScience, 1985